Taxonomy Code 1835X0200X(1835x0200x)
Oncology Pharmacist. Providers: 12
Oncology Pharmacist Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
DR. PHARMD Kristen Smith Vinik |
Individual |
50 N Medical Dr Pharmacy Room A050 Salt Lake City, UT |
|
|
DR. PHARMD Shauna Brooke Burns |
Individual |
1950 Circle Of Hope Dr Pharmacy Services Salt Lake City, UT |
|
|
PHARMD Thu M Tran |
Individual |
1950 Circle Of Hope Dr Suite 2110, Pharmacy Services Salt Lake City, UT |
|
|
PHARM.D. Lisa Annette Cox |
Individual |
2000 Circle Of Hope Dr Suite 2440 Salt Lake City, UT |
|
|
PHARMD Patricia Ann Jeppson |
Individual |
1950 Circle Of Hope Dr Ste 2110 Salt Lake City, UT |
|
|
DR. PHARM. D Daniel Sageser |
Individual |
1950 Circle Of Hope Dr Suite 2110 Salt Lake City, UT |
|
|
DR. PHARMD Jeffrey Gilreath |
Individual |
1950 Circle Of Hope Dr Salt Lake City, UT |
|
|
MR. RPH, MS Scott B Silverstein |
Individual |
1950 Circle Of Hope Dr Ste 2110p Salt Lake City, UT |
|
|
DR. PHARM.D., BCOP Christine Louise Crossno |
Individual |
2000 Circle Of Hope Dr Huntsman Cancer Institute, Dept Of Pharmacy Salt Lake City, UT |
|
|
DR. PHARMD Steven Lee Kirkegaard |
Individual |
2000 Circle Of Hope Dr Ste 2440 Salt Lake City, UT |
|
|
DR. PHARMD Courtney C Cavalieri |
Individual |
2000 Circle Of Hope Dr Salt Lake City, UT |
|
|
Gmt Pharmacy Pc |
Organization |
1890 S 3850 W Ste 220a Salt Lake City, UT |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 1835X0200X |
| Specialization | Oncology |
| Display Name | Oncology Pharmacist |
| Taxonomy Group | Pharmacy Service Providers |
| Taxonomy Classification | Pharmacist |
| Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
| Effective Date | September 30, 2009 |